Mitigation of Major Hip Injury Due to Fall With a Smart Belt
Public ClinicalTrials.gov record NCT05245097. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Mitigation of Major Hip Injury Due to Fall in an At-Risk, Older Adult Population With a Wearable Smart Belt
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Multi-center, comparative, non-significant risk adaptive study with retrospective controls. After providing informed consent and being screened for eligibility, intervention subjects will be prescribed and provided an appropriately sized Tango Belt. The subject must demonstrate a minimum of 64% adherence to the use of the Tango Belt within 14 days of initiation to fully enroll in the study. Upon demonstration of at least minimum adherence, the subject will be provided the Tango Belt to wear continuously for at least 6 months, except during bathing, device charging, and as deemed by clinical staff. The study will investigate the safety and effectiveness of the Tango Belt with the primary and secondary endpoints being taken every 3 months and at the end of the study run time from the electronic medical record. Additionally, ancillary endpoints on adverse events and device performance will be gathered.
Study identification
- NCT ID
- NCT05245097
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 471 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 29, 2022 (Actual)
- Primary completion
- Nov 3, 2023 (Actual)
- Completion
- Nov 3, 2023 (Actual)
- Last update posted
- Jun 13, 2025
2022 – 2023
United States locations
- U.S. sites
- 10
- U.S. states
- 2
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Revere Court of Sacramento | Sacramento | California | 95831 | — |
| Holy Redeemer Health System | Bensalem | Pennsylvania | 19020 | — |
| Foulkeways at Gwynedd | Gwynedd | Pennsylvania | 19436 | — |
| Country Meadows Hershey | Hershey | Pennsylvania | 17033 | — |
| Meadowood Senior Living | Lansdale | Pennsylvania | 19446 | — |
| Camilla Hall | Malvern | Pennsylvania | 19355 | — |
| Chandler Hall Health Services | Newtown | Pennsylvania | 18940 | — |
| The Heritage of Green Hills | Shillington | Pennsylvania | 19607 | — |
| Country Meadows Wyomissing | Wyomissing | Pennsylvania | 19610 | — |
| Country Meadows of York-South | York | Pennsylvania | 17403 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05245097, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 13, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05245097 live on ClinicalTrials.gov.